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SHORT COMMUNICATION
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We report the prevalence of human papillomavirus type 16 (HPV-16) variants in women with cervical lesions
from the Federal District, Central Brazil. We analyzed 34 HPV-16 samples, identifying the sequence variations of E6
and L1 genes and correlating variant frequency with disease status. The most prevalent HPV-16 variant was the
European (50%), followed by Asian-American (41.2%), African-1 (5.9%), and African-2 (2.9%). European and
non-European variants appeared in equal frequencies among the cytological types of lesions – atypical squamous
or glandular cells of undetermined significance, cytological alterations suggesting HPV infection, cervical
intraepithelial neoplasias, squamous cell carcinoma, and adenocarcinoma.
Key words: human papillomavirus type 16 - variants - Federal District, Brazil
Human papillomaviruses (HPVs) have been consis-
tently associated with invasive cervical carcinoma (ICC)
and cervical intraepithelial neoplasias (CINs) (Lehtinen et
al. 2001, Matsukura & Sugaset 2001). Worldwide, HPV-16
is considered the most prevalent of the more than 20 dif-
ferent HPV types associated with cervical lesions (Bosch
et al. 1995). Within an HPV type, variants are defined by
nucleotide substitutions of up to 2% in E6 and L1 genes
and by up to 5% in the LCR (Chan et al. 1995). HPV-16
variants can be clustered in 5 groups: African-1, African-
2, Asian, Asian-American, and European (Stewart et al.
1996, Yamada et al. 1997). The sequence considered to be
the reference, mentioned as the prototype (Seedorf et al.
1985), belongs to the European branch.
The purpose of the present study is to describe the
prevalence of HPV-16 variants in cervical specimens from
the Federal District, Central Brazil, as well as to investi-
gate a possible differential variant associated pathoge-
nicity in this population.
Thirty four HPV-16 variants were identified by poly-
merase chain reaction (PCR) amplification and automated
sequencing of the MY09/MY11 (Bernard et al. 1994) L1
region and the entire E6 gene, amplified by primers E6A/
E6S (Gibco) (Wheeler et al. 1997). The same primers were
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used for automatically sequencing the 2 strands of the
amplified products using a Megabace System (Amersham
Pharmacia). The base positions of all sequences obtained
were numbered after basic local alignment search tool
(BLAST) analysis (Altschul et al. 1997), and the variant
designation followed the classification of Wheeler et al.
(1997).
The most prevalent HPV-16 variant was the European
(17 out of 34, 50%), followed by the Asian-American (14
out of 34, 41.2%), African-1 (2 out of 34, 5.9%), and Afri-
can-2 (1 out of 34, 2.9%). Only one of the European vari-
ants was an E-350G variant. HPV-16 non-European and
European variants were detected at similar frequencies
among the cytological types of lesions, revealing an uni-
form distribution (Table I). We identified one nucleotide
substitution in an Asian-American variant (Bsb-81) that
had not been reported previously by other authors. It
occurred at position 80 (thymine to guanine) (Table I),
between a TATA signal (from nucleotide 65 to 71) and the
beginning of the E6 coding region (from nucleotide 83 to
559).
Considering all variants, 12 different point mutations
were detected within the E6 segment, spanning nucle-
otides 31 and 683. Seven different point mutations were
detected within the L1 segment, spanning nucleotides 6584
and 7035 (Table I). Altogether, 8 point mutations in 7 nucle-
otide positions generated amino acid changes in E6 and
in L1 proteins (Table II).
In Brazil, similar to the prevalence of HPV-16 Euro-
pean variants in the Federal District (50%), Villa et al. (2000)
detected European variants in 54% of the patients in São
Paulo. However, in our study, the percentage of patients
positive for Asian-American variants (41.2%) was higher
than that reported by other authors. Villa et al. (2000) de-
tected Asian-American variants in 22% of the patients
and Yamada et al. (1997), in an international study, de-
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tected Asian-American variants in 19.7% of the patients
living in Central and South America.
Our results suggest that HPV-16 non-European vari-
ants do not represent an additional factor associated with
increased occurrence of high grade cervical lesions in the
studied population, as European and non-European vari-
ants appeared in equal frequencies among the cytologi-
cal types of lesions. Nindl et al. (1999) also did not find
any correlation between variants and severity of the le-
sion.
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TABLE I
Nucleotide correlation of human papillomavirus type 16 prototype and variants. The nucleotide positions are indicated vertically.
Positions at which no variation was found are marked with traces, whereas a letter indicates a variant nucleotide at this position.
Analyses according to Wheeler et al. (1997)
Variant E6 DNA sequence L1 DNA sequence  N
6 6 6 6 6 6 6
1 1 1 1 2 2 3 3 4 5 6 7 8 8 8 9 9
8 0 3 4 4 8 8 3 5 0 3 9 2 0 5 6 7 9
0 9 2 3 5 6 9 5 0 3 2 5 1 3 4 5 0 4
HPV-16R T T G C G T A C T A A A G A C C C G
E-P - - - - - - - - - - - - - - - - - - 16
E-350G - - - - - - - - G - - - - - - - - - 1
AA - - - - T A G T G - G C A T T T T A 13
Af1 - - C G T A G T - - - - A - T - T A 2
Af2 - C T G T A G T - G - C A - T T T A 1
Bsb-81 G - - - T A G T G - G C A T T T T A 1
TABLE II
 Amino acid correlation of human papillomavirus type 16
prototype and variants. The position of amino acid change is
stated numerically. The letter preceding this number refers to
the prototype amino acid, and the letter after it refers to its
substitution
                                 Mutation description
Variant E6 protein L1 protein
E-350G L83V –
AA Q14H, H78Y, L83V T379P, T415S
Af-1 R10T, Q14D, H78Y –
Af-2 R10I, Q14D, H78Y T379P
